Digital Content

We use cookies to enhance your browsing experience, serve personalized ads or content, and analyze our traffic. We’ll assume you’re ok with this, but you can opt out if you wish. See our 

Footer

2025 Event

Column Name Goes Here

Footer V2

2024 Event

Event Global

New HLTH Insights Programs

Become a Hosted Buyer

Become a Sponsor/Exhibitor

Apply for Media Pass

Promote Your Presence

2023 Event

Event Global Footer

Startup Opportunities

Hotel

2022 Event

LLC Global

2021 Event

LLC Menu Official

LLC Menu

When a person suffers a stroke or traumatic brain injury, delays of even a few hours to proper treatment can mean the difference between recovery and permanent disability or death. Time is brain. The need to eliminate these costly delays is what led a team of physicians who specialize in emergency medicine, neurology and neurocritical care to create the technology behind Sense Neuro Diagnostics.  

Different types of stroke and traumatic brain injury require different types of immediate treatment.  First responders currently have no tools to diagnose stroke subtype and often simply transport a patient to the nearest hospital, which may not be equipped to provide the critical care a patient needs.  In the hospital ICU, medical staff have no tools to monitor brain injury objectively and continuously in the hospital, in real time, in between CT scans, instead relying on a checklist of observations and patient questions. which can leave a bleed undetected for hours.
Sense is developing technology to enable continuous, real-time brain injury monitoring in the hospital ICU, as well as rapid detection of traumatic brain injury and important stroke subtypes in a field environment. Our non-invasive brain scanners fit on a patient’s head like a cap, completing a scan of the patient’s brain in 2.5 seconds.  Our monitoring device is in a pivotal trial at multiple US hospital sites.  Following a successful first-in-human pilot study with 99% accuracy, our triage technology is expected to begin a pivotal trial in early 2022.  Sense has been awarded a $2.43M Department of Defense contract to develop a device for military use in detecting and monitoring traumatic brain injury, a signature war wound, in a field environment.

Sense Neuro Diagnostics - HLTH 2021 Sponsor

Scripta Insights, a company founded by doctors, is using technology to create transparency, disrupt and improve the $300B self-funded pharmacy benefits marketplace. Scripta is a healthcare IT solution that delivers immediate, real savings on pharmacy benefit costs for self-insured employers, payers and their members. It empowers companies to take control of their pharmacy spend, while helping members get the medicine they need at the best possible price. Scripta&#39;s proprietary software, <a href="https://Script.AI" target="_blank">Script.AI</a>, was developed over a decade and is designed to analyze millions of pharmacy transactions in mere seconds to yield actionable insights. It uses data analytics, AI and expert insights from its P&amp;T Committee to recognize savings opportunities that, until now, have been impossible to identify. Scripta has saved employers and members millions of dollars on prescriptions.

Scripta Insights - HLTH 2021 Sponsor

Semantic Health helps hospitals and health systems unlock the true value of their unstructured clinical data. Their intelligent medical coding and auditing platform uses artificial intelligence and deep learning to streamline medical coding &amp; auditing concurrent with patient admission, improve documentation quality, optimize reimbursements, and enable real-time access to coded data for secondary analysis.

Semantic Health - HLTH 2021 Sponsor